Net profit of Natco Pharma rose 83.55% to Rs 677.30 crore in the quarter ended September 2024 as against Rs 369.00 crore during the previous quarter ended September 2023. Sales rose 32.94% to Rs 1371.10 crore in the quarter ended September 2024 as against Rs 1031.40 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
Sales | 1371.10 | 1031.40 | 33 |
OPM % | 58.66 | 44.41 | - |
PBDT | 864.00 | 483.20 | 79 |
PBT | 818.20 | 439.60 | 86 |
NP | 677.30 | 369.00 | 84 |